Trimethoxy(methyl)silane

Genetic toxicity: in vivo

Administrative data

Endpoint:

in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus

Type of information:

experimental study

Adequacy of study:

key study

Study period:

2002-09-27 to 2002-11-28

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2002

Report date:

2003

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)

GLP compliance:

yes

Type of assay:

micronucleus assay

Test material

Test material information

Constituent 1

Reference substance name:

Trimethoxy(methyl)silane

EC Number:

214-685-0

EC Name:

Trimethoxy(methyl)silane

Cas Number:

1185-55-3

Molecular formula:

C4H12O3Si

IUPAC Name:

trimethoxy(methyl)silane

Test material form:

liquid

Test animals

Species:

mouse

Strain:

CD-1

Sex:

male/female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: Harlan Italy
- Age at study initiation: no information
- Weight at study initiation: 20.8-27.2 g
- Assigned to test groups randomly: [no/yes, under following basis: ]
- Fasting period before study: no
- Housing: 5 animals per cage, polycarbonate with stainless steel mesh lid and floor
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22
- Humidity (%): 55
- Air changes (per hr): no information
- Photoperiod (hrs dark / hrs light):12/12

IN-LIFE DATES: From: not given To: 2002-10-04

Administration / exposure

Route of administration:

oral: gavage

Details on exposure:

PREPARATION OF DOSING SOLUTIONS: prepared immediately before use in corn oil

Frequency of treatment:

Single treatment

Post exposure period:

Samples taken at 24 or 48 hours

Doses / concentrations

Doses / concentrations 1

Dose / conc.:

500 mg/kg bw/day

Remarks:

expressed in terms of material as received. Solutions prepared on w/v basis without correction for displacement

Doses / concentrations 2

Dose / conc.:

1 000 mg/kg bw/day

Remarks:

expressed in terms of material as received. Solutions prepared on w/v basis without correction for displacement

Doses / concentrations 3

Dose / conc.:

2 000 mg/kg bw/day

Remarks:

expressed in terms of material as received. Solutions prepared on w/v basis without correction for displacement

No. of animals per sex per dose:

5/sex/dose

Control animals:

yes, concurrent vehicle

Positive control(s):

- mitomycin C
- Justification for choice of positive control(s): none given, standard control
- Route of administration: ip injection
- Doses / concentrations: 3.0 mg/kg body weight

Examinations

Tissues and cell types examined:

Bone marrow

Details of tissue and slide preparation:

CRITERIA FOR DOSE SELECTION: preliminary toxicity assay

TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields): no additional information

DETAILS OF SLIDE PREPARATION: air dried and stained with May-Gruenwald and Giesma

METHOD OF ANALYSIS: 200 PCEs per animal examined for presence of micronuclei at high power (x100, oil immersion)

OTHER:

Evaluation criteria:

A test item is considered positive if it induces a statistically significant increase, exceeding the historical range of negative control values, in the incidence of micronucleated PCEs (p<0.05) in pooled data for both sexes or for either sex considered separately.

Statistics:

Original observations of polychromatic cells from control and treated groups were compared using a modified Chi-squared evaluation

Results and discussion

Test results

Sex:

male/female

Genotoxicity:

negative

Toxicity:

yes

Vehicle controls validity:

valid

Negative controls validity:

not applicable

Positive controls validity:

valid

Any other information on results incl. tables

Animals from the high dose treatment group showed reduced activity,  ataxia and hunched posture.  Animals from the intermediate dose treatment  group showed hunched posture and an animal died after treatment.   Clinical signs and mortality were observed and provided evidence of  bioavailability of the test substance and adequate exposure time.  Following treatment with the test substance, no statistically significant  increase in the incidence of micronucleated PCE's over the control value  was observed at any dose-level, at any sampling time.  Following  treatment with the positive control Mitomycin-C, statistically  significant increases in the incidence of micronucleated PCEs over the  control values were observed, indicating the correct functioning of the  test system.  

The test was conducted at the limit dose of 2000 mg/kg bw at which signs  of toxicity were seen (mortality, reduced activity, ataxia and hunched  posture) indicating bioavailability of the test substance.  When tested  at the limit dose with no or minimum signs of toxicity and with the  positive and negative controls responding appropriately, the test is  considered valid.


The ratio of mature to immature to immature erythrocytes and the  proportion of immature erythrocytes to among total erythrocytes were  analyzed to evaluate the bone marrow cell toxicity. No inhibitory effect  on erythropoetic cell division was observed for either sex at any  sampling time. 

The report contains the values for PCE and NCE separately, as well as  ratios of NCE/PCE and PCE/(NCE+PCE). P/N ratios were not calculated in  the report.

Summary of incidence of micronucleated cells per 1000 cells, both sexes, 24 and 48 hours

Dose	Incidence of micronucleated cells/1000 PCE	PCE	NCE	NCE/PCE ratio	PCE/(NCE+PCE)
Sampling time 24 hours
0	1.0	20527	25105	1.22	0.45
500	1.0	20601	22891	1.11	0.47
1000	1.3	18525	21590	1.17	0.44
2000	0.5	20504	26333	1.28	0.44
Positive control	7.0	20847	35393	1.69	0.37
Sampling time 48 hours
0	0.9	20430	16561	0.81	0.55
2000	0.7	20491	24866	1.22	0.45

Applicant's summary and conclusion

Conclusions:

Trimethoxy(methyl)silane has been tested in a valid mouse mutagenicity study conducted according to OECD 474 and in compliance with GLP. No increase in the incidence of micronucleated PCE was observed resulting from exposure to the test substance by oral gavage up to limit concentrations. Appropriate positive and vehicle controls were included and gave expected results. It is concluded that the test substance is negative for the induction of micronuclei under the conditions of the test.